Akiso Matrona M, Abook Israel, Mureithi Marianne W, Kombo Janet, Koi Print, Musando Joel, Chirchir Ruth J, McRaven Michael D, Carias Ann M, Joseph Sarah, Anzala Omu, Hope Thomas J
Department of Medical Microbiology and Immunology, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.
KAVI - Institute of Clinical Research, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.
Front Immunol. 2025 Jul 4;16:1627807. doi: 10.3389/fimmu.2025.1627807. eCollection 2025.
Little is known about the relationship between antibody isotype in cervicovaginal mucus (CVM) and the local microenvironment and how this impacts HIV-1 transmission at the female genital mucosa.
In a cohort of 139 adult women in Kenya, we measured antibody isotypes in CVM and describe their associations with local pH, serum concentrations of estrogen and progesterone, and sexually transmitted infections (STIs), including HIV-1.
We found that immunoglobulin G2 (IgG2) was the most abundant and IgG4 was the least abundant in the CVM. Overall, IgG1 concentrations were significantly lower in CVM samples from women with bacterial vaginosis (BV) compared to those without BV. Among women with BV, IgG1 concentrations declined further as vaginal pH increased, suggesting possible pH-mediated degradation. We also report negative associations of BV status with IgG3 and IgG4. In addition, infection with and was positively associated with concentrations of IgA and IgM, respectively. We also found the relationship between antibody isotype and subclasses with HIV-1 viral mobility . IgG3 concentrations negatively correlated with CAP045 HIV-1 mobility and IgG1 concentrations negatively correlated with the mobility of the 92TH023 recombinant HIV-1 strain upon VRC01 depletion. These observations point towards a potentially protective role for IgG1 and IgG3 in trapping certain HIV-1 strains in the CVM.
Importantly, our study builds on previous work, providing a potential mechanism by which BV and STIs may modulate immunoglobulin isotype and subclass content in the CVM. These results highlight the need for proper treatment of BV and other STIs, as this could impact the effectiveness of HIV-1 vaccines targeted at enhancing specific immunoglobulin responses in the cervicovaginal mucosa.
关于宫颈阴道黏液(CVM)中的抗体亚型与局部微环境之间的关系,以及这如何影响女性生殖黏膜处的HIV-1传播,我们所知甚少。
在肯尼亚的139名成年女性队列中,我们测量了CVM中的抗体亚型,并描述了它们与局部pH值、血清雌激素和孕酮浓度以及性传播感染(STIs)(包括HIV-1)之间的关联。
我们发现免疫球蛋白G2(IgG2)在CVM中含量最为丰富,而IgG4含量最少。总体而言,与无细菌性阴道病(BV)的女性相比,患有BV的女性的CVM样本中IgG1浓度显著更低。在患有BV的女性中,随着阴道pH值升高,IgG1浓度进一步下降,提示可能存在pH介导的降解。我们还报告了BV状态与IgG3和IgG4之间的负相关。此外,沙眼衣原体和淋病奈瑟菌感染分别与IgA和IgM浓度呈正相关。我们还发现了抗体亚型和亚类与HIV-1病毒流动性之间的关系。IgG3浓度与CAP045 HIV-1的流动性呈负相关,而在VRC01耗尽后,IgG1浓度与92TH023重组HIV-1毒株的流动性呈负相关。这些观察结果表明IgG1和IgG3在将某些HIV-1毒株捕获在CVM中可能具有潜在的保护作用。
重要的是,我们的研究建立在先前工作的基础上,提供了一种潜在机制,通过该机制BV和STIs可能调节CVM中的免疫球蛋白亚型和亚类含量。这些结果强调了正确治疗BV和其他STIs的必要性,因为这可能会影响旨在增强宫颈阴道黏膜中特定免疫球蛋白反应的HIV-1疫苗的有效性。